Access cutting-edge patient-reported outcome measures (proms) treatment through this clinical trial at a research site in Aurora. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Aurora location
Preparing your pre-screening questions…
Access patient-reported outcome measures (proms) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related patient-reported outcome measures (proms) treatment provided free
Check if you qualify for this patient-reported outcome measures (proms) clinical trial in Aurora, CO
No-Cost Study Care
Local to Aurora
Convenient for CO residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The goal of this pragmatic clinical trial is to learn if the WE BEAT program, a 5-week group-based online wellbeing and skill-building program, can help teens with congenital heart disease (CHD) improve their ability to handle stress. The main question it aims to answer is if participants who receive the WE BEAT program become more resilient (the ability to bounce back from from tough times or recover from something difficult) and have better quality of life compared to participants who receive usual care. The study also aims to learn if there are connections between participant-reported psychosocial data (such as resilience, feelings about one's life and one's physical, mental, and social wellbeing) and clinical outcomes. Eligible participants who are 12-17-year-old will be in the study for about 6 months and be randomized to receive either the WE BEAT program or usual care. Following completion of the primary WE BEAT intervention at Week 5, intervention arm participants will be randomized to a single-session booster session (occurring at Week 18) vs no booster session. The booster session will be provided in a similar format to the WE BEAT program. A review of all modules/skills introduced in the program will be provided. All participants will complete 4 sets of online surveys and give 3 hair/saliva samples at different timepoints. Some participants may volunteer to give optional blood and urine samples.
Sponsor: Carelon Research
Yes, this clinical trial (NCT07525843) has an active research site in Aurora, CO that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for patient-reported outcome measures (proms) treatment options in Aurora, CO, this clinical trial (NCT07525843) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Aurora research site is actively enrolling participants for this clinical trial. You'll receive care from experienced patient-reported outcome measures (proms) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all patient-reported outcome measures (proms) clinical trials near you to find additional studies recruiting in your area.
See all multiple sclerosis clinical trials recruiting in Aurora — not just this study.
Browse Multiple Sclerosis Trials in Aurora →